More Than 1M People In LMICs Treated With New Hepatitis C Regimen, WHO Says

U.N. News Centre: U.N. health strategy making access to new, revolutionary hepatitis C treatment possible
“According to the United Nations heath agency, since the approval of new medicines for hepatitis C — offering a cure rate of over 95 percent, fewer side effects, and complete cure within three months — about two years back, more than one million patients in low- and middle-income countries have been treated. … ‘Maximizing access to lifesaving hepatitis C treatment is a priority for WHO,’ said Dr. Gottfried Hirnschall, director of WHO’s Department of HIV and Global Hepatitis Programme, in a news release…” (10/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.